CDMO Avid Bioservices Inc

Price (delayed)

$24.3

Market cap

$1.48B

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$0.02

Enterprise value

$1.43B

Highlights
CDMO's net income has surged by 183% year-on-year
CDMO's gross profit has surged by 124% year-on-year and by 37% since the previous quarter

Key stats

What are the main financial stats of CDMO
Market
Shares outstanding
60.83M
Market cap
$1.48B
Enterprise value
$1.43B
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
16.15
Price to sales (P/S)
17.7
EV/EBIT
320.79
EV/EBITDA
182.95
EV/Sales
17.68
Earnings
Revenue
$80.81M
EBIT
$4.45M
EBITDA
$7.81M
Free cash flow
$9.87M
Per share
EPS
-$0.02
Free cash flow per share
$0.17
Book value per share
$1.5
Revenue per share
$1.37
TBVPS
$2.86
Balance sheet
Total assets
$168.18M
Total liabilities
$82.81M
Debt
$21.57M
Equity
$85.37M
Working capital
$53.74M
Liquidity
Debt to equity
0.25
Current ratio
1.86
Quick ratio
1.57
Net debt/EBITDA
-6.36
Margins
EBITDA margin
9.7%
Gross margin
24.6%
Net margin
5.5%
Operating margin
5.4%
Efficiency
Return on assets
-0.8%
Return on equity
-1.7%
Return on invested capital
7.9%
Return on capital employed
4.2%
Return on sales
5.5%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

CDMO stock price

How has the Avid Bioservices stock price performed over time
Intraday
2.06%
1 week
4.25%
1 month
20.96%
1 year
306.35%
YTD
110.57%
QTD
33.3%

Financial performance

How have Avid Bioservices's revenue and profit performed over time
Revenue
$80.81M
Gross profit
$19.87M
Operating income
$4.33M
Net income
$4.45M
Gross margin
24.6%
Net margin
5.5%
CDMO's net income has surged by 183% year-on-year
The operating income has soared by 172% YoY
The company's net margin has surged by 165% YoY
The operating margin has surged by 157% year-on-year

Growth

What is Avid Bioservices's growth rate over time

Valuation

What is Avid Bioservices stock price valuation
P/E
N/A
P/B
16.15
P/S
17.7
EV/EBIT
320.79
EV/EBITDA
182.95
EV/Sales
17.68
The company's EPS has surged by 89% YoY and by 78% QoQ
CDMO's price to book (P/B) is 199% more than its 5-year quarterly average of 5.4 and 84% more than its last 4 quarters average of 8.8
Avid Bioservices's equity has surged by 81% YoY and by 73% QoQ
CDMO's P/S is 153% above its last 4 quarters average of 7.0
CDMO's revenue is up by 26% year-on-year and by 11% since the previous quarter

Efficiency

How efficient is Avid Bioservices business performance
Avid Bioservices's return on invested capital has surged by 177% YoY
The company's return on sales has surged by 165% YoY
The return on assets has surged by 93% year-on-year and by 84% since the previous quarter
CDMO's return on equity has surged by 92% year-on-year and by 85% since the previous quarter

Dividends

What is CDMO's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for CDMO.

Financial health

How did Avid Bioservices financials performed over time
The total assets is 103% greater than the total liabilities
The total assets has surged by 60% year-on-year and by 48% since the previous quarter
Avid Bioservices's quick ratio has increased by 44% from the previous quarter and by 39% YoY
The company's debt is 75% lower than its equity
Avid Bioservices's equity has surged by 81% YoY and by 73% QoQ
The debt to equity is down by 48% YoY and by 43% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.